You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Details for Patent: 8,476,425


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,476,425 protect, and when does it expire?

Patent 8,476,425 protects ZERBAXA and is included in one NDA.

Summary for Patent: 8,476,425
Title:Tazobactam arginine compositions
Abstract: This disclosure provides compositions containing solid forms of tazobactam arginine, and methods of manufacturing and using these compositions.
Inventor(s): Lai; Jan-Ji (Westborough, MA), Gu; Jian-Qiao (Lexington, MA), Pathare; Pradip M. (Lexington, MA), Jurkauskas; Valdas (Cambridge, MA), Terracciano; Joseph (Concord, MA), Damour; Nicole Miller (Belmont, MA)
Assignee: Cubist Pharmaceuticals, Inc. (Lexington, MA)
Application Number:13/628,742
Patent Claim Types:
see list of patent claims
Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,476,425

Introduction

United States Patent 8,476,425, titled "Tazobactam arginine compositions," is a patent that discloses compositions containing solid forms of tazobactam arginine, along with methods for their manufacture and use. Here, we will delve into the details of the patent's scope, claims, and the broader patent landscape.

Patent Overview

The patent, assigned to a specific entity (though not specified in the provided sources), focuses on tazobactam arginine compositions. Tazobactam is a beta-lactamase inhibitor used in combination with antibiotics to combat bacterial infections.

Scope of the Patent

The scope of the patent is defined by its claims, which outline the specific inventions and innovations covered.

Claims Analysis

The patent includes multiple claims that can be categorized into several types:

  • Composition Claims: These claims define the specific compositions of tazobactam arginine, including the solid forms and their characteristics. For example, the claims might specify the polymorphic forms of tazobactam arginine, their stability, and purity[4].

  • Method Claims: These claims describe the methods for manufacturing the tazobactam arginine compositions. This includes processes such as crystallization, drying, and formulation[4].

  • Use Claims: These claims outline the intended uses of the tazobactam arginine compositions, such as their application in pharmaceutical formulations and their efficacy in treating bacterial infections[4].

Claim Language and Scope

The language used in the claims is crucial for determining the patent's scope. Here are some key aspects:

Independent Claim Length and Count

Research has shown that the length and count of independent claims can be metrics for measuring patent scope. Narrower claims, as indicated by shorter lengths and fewer counts, are often associated with a higher probability of grant and a shorter examination process[3].

Claim Breadth

The breadth of the claims in US 8,476,425 would be evaluated based on their specificity and the range of variations they cover. Broader claims might encompass a wider range of compositions and methods, but they also risk being more vulnerable to challenges during the examination process[3].

Patent Landscape

Understanding the patent landscape is essential for assessing the novelty and non-obviousness of the invention.

Prior Art

The patent landscape includes prior art that has been cited during the examination process. For US 8,476,425, prior art keywords such as "polymorph," "tazobactam arginine," and "oxo" indicate the existing knowledge in the field that the patent must differentiate itself from[4].

Global Dossier and International Search

Tools like the Global Dossier and international patent databases (e.g., EPO's esp@cenet, JPO, and WIPO's PATENTSCOPE) provide access to related applications and prior art from other countries. This helps in understanding the global patent family and any potential overlaps or conflicts[1].

Search and Examination Process

The search and examination process for US 8,476,425 would have involved several steps:

Preliminary Search

A preliminary search using tools like the USPTO's Patent Public Search or The Lens would have been conducted to identify existing patents and published applications related to tazobactam arginine compositions[1][2].

Office Actions and Responses

During the examination process, the patent office would have issued office actions indicating any issues with the claims, such as lack of novelty or non-obviousness. The applicant would have responded to these actions by amending the claims or providing arguments to overcome the objections[1].

Public Access and Resources

Public access to patent information is crucial for understanding the scope and claims of a patent.

USPTO Resources

The USPTO provides several resources, including the Patent Public Search tool, the Public Search Facility, and Patent and Trademark Resource Centers (PTRCs), which can be used to search and analyze patents like US 8,476,425[1].

Sequence Listings and Assignment Search

For patents involving biological sequences or changes in ownership, resources like the Publication Site for Issued and Published Sequences (PSIPS) and the Patent Assignment Search website are useful[1].

Key Takeaways

  • Claims Analysis: The claims of US 8,476,425 define the specific compositions, methods, and uses of tazobactam arginine, which are critical for understanding the patent's scope.
  • Patent Landscape: The patent landscape, including prior art and international searches, helps in assessing the novelty and non-obviousness of the invention.
  • Search and Examination: The search and examination process involves preliminary searches, office actions, and responses to ensure the patent meets the criteria for grant.
  • Public Resources: Public access to patent information through USPTO resources and other databases is essential for analyzing and understanding patents.

FAQs

Q1: What is the main subject of United States Patent 8,476,425? The main subject of US 8,476,425 is the compositions containing solid forms of tazobactam arginine and methods for their manufacture and use.

Q2: How are the claims of a patent like US 8,476,425 typically categorized? The claims are typically categorized into composition claims, method claims, and use claims.

Q3: What tools can be used to search for prior art related to a patent like US 8,476,425? Tools such as the USPTO's Patent Public Search, The Lens, and international patent databases like EPO's esp@cenet and WIPO's PATENTSCOPE can be used.

Q4: Why is the breadth of claims important in a patent? The breadth of claims is important because it affects the patent's scope and its vulnerability to challenges during the examination process.

Q5: Where can one find information on patent assignments and changes in ownership for a patent like US 8,476,425? Information on patent assignments and changes in ownership can be found using the Patent Assignment Search website provided by the USPTO[1].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. The Lens - Free & Open Patent and Scholarly Search: https://lens.org/180-822-204-488-168
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Google Patents - Tazobactam arginine compositions: https://patents.google.com/patent/US8476425B1/en
  5. Unified Patents Portal - US-20070286817-A1: https://portal.unifiedpatents.com/patents/patent/US-20070286817-A1

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,476,425

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Cubist Pharms Llc ZERBAXA ceftolozane sulfate; tazobactam sodium POWDER;INTRAVENOUS 206829-001 Dec 19, 2014 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.